Gain Therapeutics earnings were -$20.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest GANX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.8M, down 16% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GANX reported annual earnings of -$20.4M, with -8.3% growth. The next GANX earnings date is May 12, 2025.
What were Gain Therapeutics's earnings last quarter?
On GANX's earnings call on Invalid Date, Gain Therapeutics (NASDAQ: GANX) reported Q4 2024 earnings per share (EPS) of -$0.11, up 62.07% year over year. Total GANX earnings for the quarter were -$3.77 million. In the same quarter last year, Gain Therapeutics's earnings per share (EPS) was -$0.29.
The next GANX earnings date is Invalid Date. Add GANX to your watchlist to be reminded of Gain Therapeutics's next earnings date.
What was GANX's earnings growth in the past year?
As of Gain Therapeutics's earnings date in Invalid Date, Gain Therapeutics's earnings has grown year over year. GANX earnings in the past year totalled -$20.41 million.
Is Gain Therapeutics profitable or losing money?
As of the last Gain Therapeutics earnings report, Gain Therapeutics is currently losing money. Gain Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$20.41 million, a 8.34% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.